Platelet BioGenesis Receives $56 Million Contract from BARDA

01Oct

Platelet BioGenesis Receives $56 Million Contract from BARDA

Portfolio News
Platelet BioGenesis Receives $56 Million Contract from the Biomedical Advanced Research and Development Authority (BARDA) to Develop Human Stem Cell-Derived Platelets as a Medical Countermeasure to Radiological and Nuclear Exposure. Read more >>

Share this post

Related Posts

24May

How Much Each Company Will Charge to Take You to Space

The first issue of Airbnbmag, which hits newsstands today, will help you find a place to stay off-planet, too. Here... read more
27Feb

Sharp vision: New glasses help the legally blind see

The headsets from eSight transmit images from a forward-facing camera to small internal screens — one for each eye —... read more
24Mar

Aras Named a Leader in Product Lifecycle Management by Independent Research Firm

Aras, a provider of the most powerful low-code platform with applications to design, build and operate complex products, today announced... read more
15May

Myomo® Application for Medicare Codes Receives Favorable Preliminary Decision

Myomo, Inc., a wearable medical robotics company, announces that the Centers for Medicare & Medicaid Services ("CMS") has published a... read more
28Sep

Cloud-Storage Firm Wasabi Reaches $1.1 Billion Valuation

Wasabi Technologies Inc., a Boston-based cloud-storage startup, has reached unicorn status with its latest fundraising. Read more... read more
02Dec

Pixability and Playground xyz Partner To Deliver Attention Measurement for YouTube

Pixability, (www.pixability.com), a leader in AI-driven contextual targeting, brand suitability and performance on YouTube and CTV, today announced that it... read more
06Jan

Daktari Announces Formation of Scientific Advisory Board

Daktari Diagnostics, a company focused on making “Anywhere. Care.™” a reality with its portable and ultrasensitive immunoassay-based CarePlatform™, today announced... read more
17Jan

Myomo to Present at Noble Capital Markets’ 14th Annual Investor Conference

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that it will... read more
30Jun

Announcing the addition of Dr. Jan Suchodolski to the Anubis Bio Advisory Team

Anubis Bio, the parent company behind DoggyStat, the first product of its kind to use passive immunity to treat canine... read more
15Oct

Pixability Announces Wide Release Of BrandShield, AI-Powered Brand Suitability Solution For YouTube & YouTube On TV

Pixability (www.pixability.com), the leading provider of software and insights for video advertising on YouTube and Connected TV (CTV), today announced... read more